ESPR Price Targets and Analyst Ratings NASDAQ:ESPR
ESPR Forecast. What You Should Know.
ESPR Historical Ratings and Targets
About Esperion Therapeutics
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a... ESPR Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.